Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative Neoplasms
Clinical trial NCT04858256 · RECRUITING
Trial details
- NCT number
- NCT04858256
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-29
- Primary completion
- 2027-11-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.